Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Thiamine
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== High-Dose Thiamine == In a series of small case studies published between 2013 and 2018, Alberto Costantini and colleagues found that high doses of thiamine substantially reduced [[fatigue]] in people with a range of neurological and inflammatory conditions, including Parkinson's Disease,<ref>{{Cite journal | last =Costantini | first = Antonio | last2 = Fancellu | first2 = Roberto | date = 2016 | title=An open-label pilot study with high-dose thiamine in Parkinson's disease|url=http://www.nrronline.org/text.asp?2016/11/3/406/179047|journal=Neural Regeneration Research|language=en|volume=11|issue=3|pages=406|doi=10.4103/1673-5374.179047|issn=1673-5374|pmc=PMC4828997|pmid=27127471}}</ref><ref>{{Cite journal | last =Costantini | first = Antonio | last2 = Pala | first2 = Maria Immacolata | last3 = Grossi | first3 = Enzo | last4 = Mondonico | first4 = Stella| last5 = Cardelli | first5 = Luisa Ercoli | last6 = Jenner | first6 = Carina | last7 = Proietti | first7 = Sabrina | last8 = Colangeli | first8 = Marco | last9 = Fancellu | first9 = Roberto | date = Dec 2015 | title = Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study|url=http://www.liebertpub.com/doi/10.1089/acm.2014.0353|journal=The Journal of Alternative and Complementary Medicine|language=en|volume=21|issue=12 | pages = 740–747|doi=10.1089/acm.2014.0353|issn=1075-5535}}</ref> [[multiple sclerosis]],<ref>{{Cite journal | last =Costantini | first = A. | last2 = Nappo | first2 = A. | last3 = Pala | first3=M.I. | last4 = Zappone | first4 = A. | date = 2013-07-16 | title = High dose thiamine improves fatigue in multiple sclerosis|url=https://casereports.bmj.com/lookup/doi/10.1136/bcr-2013-009144|journal=Case Reports|language=en|volume=2013|issue=|pages=bcr2013009144–bcr2013009144|doi=10.1136/bcr-2013-009144|issn=1757-790X|pmc=PMC3736110|pmid=23861280}}</ref> [[fibromyalgia]],<ref>{{Cite journal | last =Costantini | first = A. | last2 = Pala | first2 = M.I. | last3 = Tundo | first3 = S. | last4 = Matteucci | first4 = P. | date = 2013-05-20 | title = High-dose thiamine improves the symptoms of fibromyalgia|url=https://casereports.bmj.com/lookup/doi/10.1136/bcr-2013-009019|journal=Case Reports|language=en|volume=2013|issue=may20 1|pages=bcr2013009019–bcr2013009019|doi=10.1136/bcr-2013-009019|issn=1757-790X|pmc=PMC3669831|pmid=23696141}}</ref> [[inflammatory bowel disease]],<ref>{{Cite journal | last =Costantini | first = Antonio | last2 = Pala | first2 = Maria Immacolata | date = Aug 2013 | title = Thiamine and Fatigue in Inflammatory Bowel Diseases: An Open-label Pilot Study|url=http://www.liebertpub.com/doi/10.1089/acm.2011.0840|journal=The Journal of Alternative and Complementary Medicine|language=en|volume=19|issue=8 | pages = 704–708|doi=10.1089/acm.2011.0840|issn=1075-5535}}</ref> and [[migraine|cluster headaches]].<ref>{{Cite journal | last = Antonio | first = Costantini | last2 = Massimo | first2 = Tiberi | last3 = Gianpaolo | first3 = Zarletti | last4 = Immacolata | first4 = Pala Maria| last5 = Erika | first5 = Trevi | date = 2018 | title=Oral High-Dose Thiamine Improves the Symptoms of Chronic Cluster Headache|url=https://www.hindawi.com/journals/crinm/2018/3901619/|journal=Case Reports in Neurological Medicine|language=en|volume=2018|pages=1–5|doi=10.1155/2018/3901619|issn=2090-6668|pmc=PMC5932500|pmid=29850313}}</ref> Costanini and colleagues generally reported amounts between 600 and 1,800 mg of oral thiamine hydrochloride in their case studies, eventually articulating a dosage regime based on weight and sex. (They have developed a different dosage for Parkinson's Disease.) In 2020, Bager and colleagues applied a similar approach in a double-blind crossover randomized controlled trial, finding 600 to 1,800 mg of oral thiamine hydrochloride to be effective in relieving fatigue in patients with quiescent IBD.<ref>{{Cite journal | last =Bager | first=Palle|author-link = | last2 = Hvas | first2=Christian | authorlink2 = | last3 = Rud | first3=Charlotte | author-link3 = | last4 = Dahlerup | first4 = Jens | author-link4 = | date = Oct 2020 | title = Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease.|url=https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.16166|journal=Aliment Pharmacol Ther.|volume=53|issue=1 | pages = 79–86.|doi=10.1111/apt.16166|pmc=|pmid=|access-date=2021-08-22|quote=|via=}}</ref> Bager and colleagues found that the reductions in fatigue were not limited to patients with thiamine deficiency, a result also found by Costantini and colleagues. In their articles on high-dose thiamine, Costantini and colleagues offered a number of explanations for why high-dose thiamine might reduce fatigue, including a hypothesis that high doses of thiamine might be compensating for defects in the active transport mechanism that allows thiamine to enter the cell and be used by the [[mitochondria]] to produce energy. Under this hypothesis, which Bager and colleagues also posit, large doses of thiamine are necessary to allow blood thiamine levels to rise to the point where thiamine could enter the cells through passive diffusion. An alternative explanation, summarized in a letter to the editor commenting on the Bager study,<ref name=":0">{{Cite journal | last =Lubell | first = Jeffrey | author-link = | date = Mar 2021 | title = Letter: future studies of high-dose thiamine should consider whether its effects on fatigue are related to the inhibition of carbonic anhydrase isoenzymes|url=https://onlinelibrary.wiley.com/doi/full/10.1111/apt.16275|journal=Aliment Pharmacol Ther.|volume=53|issue= | pages = 851-852|doi=|pmc=|pmid=|access-date=2021-08-22|quote=|via=}}</ref> focuses on high-dose thiamine's property as a carbonic anhydrase inhibitor, which has been proven in vitro,<ref>{{Cite journal | last =Özdemir | first=Zafer Ömer | last2=Şentürk | first2 = Murat | last3 = Ekinci | first3 = Deniz | date = 2013-04-01 | title = Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules|url=https://www.tandfonline.com/doi/full/10.3109/14756366.2011.637200|journal=Journal of Enzyme Inhibition and Medicinal Chemistry|language=en|volume=28|issue=2|pages=316–319|doi=10.3109/14756366.2011.637200|issn=1475-6366}}</ref> though not yet studied in vivo. As hypothesized in the letter, "The inhibition of carbonic anhydrase isoenzymes by high-dose thiamine and the resulting production of carbon dioxide could lead to reductions in fatigue and other symptomatic improvement through one or more of four potential pathways: (a) by reducing intracranial hypertension and/or ventral brainstem compression; (b) by increasing blood flow to the brain; (c) by facilitating aerobic cellular respiration and lactate clearance through the Bohr effect<ref>{{Cite journal | last = Vesela | first=A | authorlink = | last2 = Wilhelm | first2 = J | authorlink2 = | date = 2002 | title=The role of carbon dioxide in free radical reactions of the organism.|url=https://pubmed.ncbi.nlm.nih.gov/12449430/|journal=Physiol Res.|volume=51|issue=4|pages=335–33|doi=|pmc=|pmid=12449430|access-date=|quote=|via=}}</ref>; or (d) by dampening the pro-inflammatory Th-17 pathway<ref>{{Cite journal | last = Vatsalya | first = Vatsalya | last2 = Li | first2 = Fengyuan | last3 = Frimodig | first3 = Jane | last4 = Gala | first4 = Khushboo S. | last5 = Srivastava | first5 = Shweta | last6 = Kong | first6 = Maiying | last7 = Ramchandani | first7 = Vijay A. | last8 = Feng | first8 = Wenke | last9 = Zhang | first9 = Xiang | date = 2021-03-02 | title = Repurposing Treatment of Wernicke–Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile|url=https://www.frontiersin.org/articles/10.3389/fphar.2020.598128/full|journal=Frontiers in Pharmacology|volume=11|pages=598128|doi=10.3389/fphar.2020.598128|issn=1663-9812|pmc=PMC7960760|pmid=33737877}}</ref>, again through the Bohr effect, potentially mediated by reductions in hypoxia-inducible factor 1.<ref>{{Cite journal | last =Nutsch | first = Katherine | last2 = Hsieh | first2 = Chyi | date = Sep 2011 | title = When T Cells Run Out of Breath: The HIF-1α Story|url=https://linkinghub.elsevier.com/retrieve/pii/S0092867411009445|journal=Cell|language=en|volume=146|issue=5 | pages = 673–674|doi=10.1016/j.cell.2011.08.018}}</ref><ref name=":0" />. A more complete explanation of this hypothesis can be found here.{{Citation needed | date = 2021}} Studies have also examined the potential of the thiamine derivative, sulbutiamine, to reduce fatigue.<ref>{{Cite journal | last =Sevim | first = Serhan | last2 = Kaleağası | first2 = Hakan | last3 = Taşdelen | first3=Bahar | date = Aug 2017 | title = Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis|url=https://linkinghub.elsevier.com/retrieve/pii/S2211034817301190|journal=Multiple Sclerosis and Related Disorders|language=en|volume=16|pages=40–43|doi=10.1016/j.msard.2017.05.010}}</ref>
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
This page is a member of 2 hidden categories:
Category:All articles with unsourced statements
Category:Articles with unsourced statements from 2021
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs